Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016155274> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W2016155274 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DC(Background) Cisplatin is a commonly used chemotherapy agent for many kinds of cancers including head and neck cancer. Chemoresistance to cisplatin significantly contributes to treatment failure in clinical practice. The MRE11/RAD50/NBS1 (MRN) complex is well known a major DNA repair system. Our previous in vitro study shows that enhanced DNA repairing by MRN is a critical molecular mechanism for cisplatin-based chemoresistance. The present study further investigates if the finding of enhanced DNA repairing is responsible for cisplatin-based chemoresistance with human head and neck squamous cell carcinoma (HNSCC) in an animal model and, more important, if this finding correlates to the clinical study with patients who suffer from HNSCC.(Methods) An animal model with human HNSCC was used for this study. Tumor volume changes were measured before and after cisplatin treatment. Immunohistochemistry studies were carried out for detecting the expression levels of MRN and apoptosis. The chemoresistant profile of the tumor model was established depending on these studies. The patients with HNSCC who initially received cisplatin monotherapy along with the patients without having cisplatin treatment were investigated. Immunohistochemistry studies were carried out for detecting the expression levels of MRN and apoptosis. These results were carefully analyzed by using a linear regression model with random effects to compare with established animal tumor model and in vitro findings.(Results) Our animal model with human HNSCC demonstrated that chemoresistance to cisplatin is associated with increased expression levels of MRN after cisplatin treatment (p<0.0001(MRE11), p<0.0001(RAD50), p<0.0001(NBS1)). In addition, the resistant tumors showed decreased levels of apoptosis after cisplatin treatment (p<0.0001). Our clinical study confirms these findings as shown that patients with HNSCC had increased expression of MRN when developing cisplatin chemoresistnace.(Conclusion) It is strongly suggested that increased expression levels of MRN proteins after cisplatin treatment are associated with a resistant phenotype in the human HNSCC. Our study presents important findings that will facilitate a better understanding of the molecular mechanisms underlying tumor cell resistance to chemotherapy.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 2573." @default.
- W2016155274 created "2016-06-24" @default.
- W2016155274 creator A5007235827 @default.
- W2016155274 creator A5017991749 @default.
- W2016155274 creator A5057978718 @default.
- W2016155274 creator A5063547580 @default.
- W2016155274 creator A5068216885 @default.
- W2016155274 date "2010-04-15" @default.
- W2016155274 modified "2023-10-17" @default.
- W2016155274 title "Abstract 2573: Molecular mechanism of cisplatin-based chemoresistance with human head and neck cancer: A translational clinical study" @default.
- W2016155274 doi "https://doi.org/10.1158/1538-7445.am10-2573" @default.
- W2016155274 hasPublicationYear "2010" @default.
- W2016155274 type Work @default.
- W2016155274 sameAs 2016155274 @default.
- W2016155274 citedByCount "0" @default.
- W2016155274 crossrefType "proceedings-article" @default.
- W2016155274 hasAuthorship W2016155274A5007235827 @default.
- W2016155274 hasAuthorship W2016155274A5017991749 @default.
- W2016155274 hasAuthorship W2016155274A5057978718 @default.
- W2016155274 hasAuthorship W2016155274A5063547580 @default.
- W2016155274 hasAuthorship W2016155274A5068216885 @default.
- W2016155274 hasConcept C104317684 @default.
- W2016155274 hasConcept C121608353 @default.
- W2016155274 hasConcept C126322002 @default.
- W2016155274 hasConcept C143998085 @default.
- W2016155274 hasConcept C190283241 @default.
- W2016155274 hasConcept C204232928 @default.
- W2016155274 hasConcept C2775984157 @default.
- W2016155274 hasConcept C2776530083 @default.
- W2016155274 hasConcept C2776694085 @default.
- W2016155274 hasConcept C2776833033 @default.
- W2016155274 hasConcept C2778239845 @default.
- W2016155274 hasConcept C502942594 @default.
- W2016155274 hasConcept C55493867 @default.
- W2016155274 hasConcept C71924100 @default.
- W2016155274 hasConcept C86339819 @default.
- W2016155274 hasConcept C86803240 @default.
- W2016155274 hasConcept C94966510 @default.
- W2016155274 hasConceptScore W2016155274C104317684 @default.
- W2016155274 hasConceptScore W2016155274C121608353 @default.
- W2016155274 hasConceptScore W2016155274C126322002 @default.
- W2016155274 hasConceptScore W2016155274C143998085 @default.
- W2016155274 hasConceptScore W2016155274C190283241 @default.
- W2016155274 hasConceptScore W2016155274C204232928 @default.
- W2016155274 hasConceptScore W2016155274C2775984157 @default.
- W2016155274 hasConceptScore W2016155274C2776530083 @default.
- W2016155274 hasConceptScore W2016155274C2776694085 @default.
- W2016155274 hasConceptScore W2016155274C2776833033 @default.
- W2016155274 hasConceptScore W2016155274C2778239845 @default.
- W2016155274 hasConceptScore W2016155274C502942594 @default.
- W2016155274 hasConceptScore W2016155274C55493867 @default.
- W2016155274 hasConceptScore W2016155274C71924100 @default.
- W2016155274 hasConceptScore W2016155274C86339819 @default.
- W2016155274 hasConceptScore W2016155274C86803240 @default.
- W2016155274 hasConceptScore W2016155274C94966510 @default.
- W2016155274 hasLocation W20161552741 @default.
- W2016155274 hasOpenAccess W2016155274 @default.
- W2016155274 hasPrimaryLocation W20161552741 @default.
- W2016155274 hasRelatedWork W1523474566 @default.
- W2016155274 hasRelatedWork W1968719953 @default.
- W2016155274 hasRelatedWork W1994065293 @default.
- W2016155274 hasRelatedWork W2035433865 @default.
- W2016155274 hasRelatedWork W2107015211 @default.
- W2016155274 hasRelatedWork W2490393458 @default.
- W2016155274 hasRelatedWork W2510558994 @default.
- W2016155274 hasRelatedWork W2561107175 @default.
- W2016155274 hasRelatedWork W2769212673 @default.
- W2016155274 hasRelatedWork W2772577167 @default.
- W2016155274 hasRelatedWork W2792623786 @default.
- W2016155274 hasRelatedWork W2796336408 @default.
- W2016155274 hasRelatedWork W2804395602 @default.
- W2016155274 hasRelatedWork W2894996514 @default.
- W2016155274 hasRelatedWork W2969060245 @default.
- W2016155274 hasRelatedWork W3034493637 @default.
- W2016155274 hasRelatedWork W3042306985 @default.
- W2016155274 hasRelatedWork W3048408867 @default.
- W2016155274 hasRelatedWork W3135623355 @default.
- W2016155274 hasRelatedWork W3206717219 @default.
- W2016155274 isParatext "false" @default.
- W2016155274 isRetracted "false" @default.
- W2016155274 magId "2016155274" @default.
- W2016155274 workType "article" @default.